Abbratech Inc.

Branford, US · 1 known investors

AbbraTech develops a platform technology for discovering and validating antibody therapies targeting disease. The platform enables antibody discovery against drug targets previously inaccessible through conventional methods, particularly for cancer, immune disorders, and viral infections.

Biotech